900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Bergamasco dog breed	Moved elsewhere
Berger Shetland dog breed	Moved elsewhere
Berger de Picard dog breed	Moved elsewhere
Berger de Pyrenees dog breed	Moved elsewhere
Berger du Languedoc dog breed	Moved elsewhere
Bergers IgA- eller IgG-nefropati	Ambiguous
senil chorea	A component that is no longer current, useful, appropriate or acceptable.
Bergeyella-art	Ambiguous
Beriberi	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beriberi heart disease	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Berkshire pig	Moved elsewhere
Berlesiella-art	Ambiguous
Bermuda grass pollen allergen	Ambiguous
Bermuda petrel	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Berne-virus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bernese Hound dog breed	Moved elsewhere
Bernese mountain dog	Moved elsewhere
Berrendas cattle breed	Moved elsewhere
Berry-aneurisme	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Berthing superintendent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Berthingman	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bertolotti's syndrome	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beryllium OG/ELLER berylliumforbindelse	A component that fails to comply with the current editorial guidance.
Besnoitia-art	Ambiguous
Bespoke shoes	Ambiguous
Best ever peak flow rate	Ambiguous
Best ever peak flow rate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bestuzhev cattle breed	Moved elsewhere
Beta 1 blocking product	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta 2 glycoprotein 1 level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta 2 glycoprotein 1 level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker contraindicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker contraindicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
glaukompræparat med betablokker	A component that fails to comply with the current editorial guidance.
Beta blocker indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker not indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker not indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker prophylaxis	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker prophylaxis	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker therapy refused	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker therapy refused	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
interferon-beta	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta source contact therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta thalassaemia trait	Ambiguous
Beta thalassaemia trait	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta thalassaemia: (& minor)	Ambiguous
Beta tocopherol + gamma tocopherol	A component that is no longer current, useful, appropriate or acceptable.
allergi over for beta-adrenoceptoragonist	A component that fails to comply with the current editorial guidance.
Beta-adrenoceptor blocking drug	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-aspartyl-peptidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-endorphin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-galactocerebrosidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-galactocerebrosidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-glucuronidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-glucuronidase test	Ambiguous
beta-glucuronidase-test	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-hemolytic Streptococcus, group B	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
måling af beta-hydroxybutyrat	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
beta-hydroxyisobutyryl-CoA-deacylasemangel	Ambiguous
Betaherpesvirus group	A component that is no longer current, useful, appropriate or acceptable.
Betahistine dihydrochloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betahistine hydrochloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
betain, vandfrit 1 g/måleske pulver	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone + antimicrobials	Ambiguous
betamethason 0,1 % creme	A component that is no longer current, useful, appropriate or acceptable.
betamethason 0,1 % lotion	A component that is no longer current, useful, appropriate or acceptable.
betamethason 0,1 % salve	A component that is no longer current, useful, appropriate or acceptable.
betamethason 0,1 % til anvendelse i hårbunden	A component that fails to comply with the current editorial guidance.
betamethason 0,6 mg/5 ml syrup	A component that is no longer current, useful, appropriate or acceptable.
betamethason 4 mg/ml injektionsvæske, opløsning, ampul a 1 ml	Ambiguous
betamethason 500 µg opløselig tablet	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan	A component that is no longer current, useful, appropriate or acceptable.
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension	A component that is no longer current, useful, appropriate or acceptable.
betamethasonbenzoatpræparat til topikal anvendelse	A component that fails to comply with the current editorial guidance.
Betamethasone dipropionate + clotrimazole	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
betamethasondipropionat 0,5 mg + clotrimazol 10 mg lotion	A component that fails to comply with the current editorial guidance.
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
betamethasondipropionat 0,05 % gel	A component that is no longer current, useful, appropriate or acceptable.
betamethasondipropionat 0,05 % lotion	A component that is no longer current, useful, appropriate or acceptable.
betamethasondipropionat 0,5 % salve	A component that is no longer current, useful, appropriate or acceptable.
betamethasondipropionat 0,5 mg creme	A component that is no longer current, useful, appropriate or acceptable.
betamethasondipropionat 0,5 mg/g creme	A component that is no longer current, useful, appropriate or acceptable.
betamethasondipropionat 0,5 mg/g salve	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone sodium phospha 15mg/5mL injection	A component that fails to comply with the current editorial guidance.
Betamethasone sodium phospha 3mg/mL injection	A component that fails to comply with the current editorial guidance.
Betamethasone sodium phospha 4mg/mL injection	A component that fails to comply with the current editorial guidance.
betamethasondinatriumphosphat 3 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	A component that fails to comply with the current editorial guidance.
betamethasondinatriumphosphat 4 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	A component that fails to comply with the current editorial guidance.
Betamethasone valerate 0.12%	A component that fails to comply with the current editorial guidance.
betamethasonvalerat 0,12 % aerosol	A component that fails to comply with the current editorial guidance.
betamethasonvalerat 0,12 % skum	Ambiguous
betamethasonvaleratpræparat til systemisk anvendelse	Ambiguous
betamethason 0,05 % + clotrimazol 1 % creme	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone+neomycin sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
betamethason + salicylsyre 0,05/3 % til anvendelse i hårbunden	A component that fails to comply with the current editorial guidance.
Betatron electron therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betatron photon therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betaxolol 0.25% conventional release eye drops	A component that fails to comply with the current editorial guidance.
betaxolol 0,25% øjendråber til engangsbrug	A component that fails to comply with the current editorial guidance.

Start Previous Page 163 of 1405 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)